Entries of Volin, Liisa on the publication server
 | Up a level |
Number of items: 4.
2019
Robin, Marie, de Wreede, Liesbeth C., Wolschke, Christine, Schetelig, Johannes, Eikema, Diderik-Jan, Van Lint, Maria Teresa, Knelange, Nina Simone, Beelen, Dietrich, Brecht, Arne, Niederwieser, Dietger, Vitek, Antonin, Bethge, Wolfgang, Arnold, Renate, Finke, Jürgen, Volin, Liisa, Yakoub-Agha, Ibrahim, Nagler, Arnon, Poiré, Xavier, Einsele, Hermann, Chevallier, Patrice, Holler, Ernst, Ljungman, Per, Robinson, Stephen, Radujkovic, Alekxandar, McLornan, Donal, Chalandon, Yves and Kröger, Nicolaus
(2019)
Long-term outcome after allogeneic hematopoietic cell transplantation for myelofibrosis.
Haematologica 104 (9), pp. 1782-1788.
Fulltext not available.
2012
Finke, Jürgen, Schmoor, Claudia, Bethge, Wolfgang A., Ottinger, Hellmut D., Stelljes, Matthias, Zander, Axel R., Volin, Liisa 
, Heim, Dominik A., Schwerdtfeger, Rainer, Kolbe, Karin, Mayer, Jiri, Maertens, Johan A., Linkesch, Werner, Holler, Ernst, Koza, Vladimir, Bornhäuser, Martin, Einsele, Hermann, Bertz, Hartmut, Grishina, Olga and Socié, Gérard
(2012)
Prognostic Factors Affecting Outcome after Allogeneic Transplantation for Hematological Malignancies from Unrelated Donors: Results from a Randomized Trial.
Biology of Blood and Marrow Transplantation 18 (11), pp. 1716-1726.
Fulltext not available.
, Heim, Dominik A., Schwerdtfeger, Rainer, Kolbe, Karin, Mayer, Jiri, Maertens, Johan A., Linkesch, Werner, Holler, Ernst, Koza, Vladimir, Bornhäuser, Martin, Einsele, Hermann, Bertz, Hartmut, Grishina, Olga and Socié, Gérard
(2012)
Prognostic Factors Affecting Outcome after Allogeneic Transplantation for Hematological Malignancies from Unrelated Donors: Results from a Randomized Trial.
Biology of Blood and Marrow Transplantation 18 (11), pp. 1716-1726.
Fulltext not available.
2011
Socié, Gérard, Schmoor, Claudia, Bethge, Wolfgang A., Ottinger, Hellmut D., Stelljes, Matthias, Zander, Axel R., Volin, Liisa , Ruutu, Tapani, Heim, Dominik A., Schwerdtfeger, Rainer, Kolbe, Karin, Mayer, Jiri, Maertens, Johan A., Linkesch, Werner, Holler, Ernst, Koza, Vladimir, Bornhäuser, Martin, Einsele, Hermann, Kolb, Hans-Jochem, Bertz, Hartmut, Egger, Matthias , Grishina, Olga and Finke, Jürgen
(2011)
Chronic graft-versus-host disease: long-term results from a randomized trial on graft-versus-host disease prophylaxis with or without anti–T-cell globulin ATG-Fresenius.
Blood 117 (23), pp. 6375-6382.
Fulltext not available.
, Ruutu, Tapani, Heim, Dominik A., Schwerdtfeger, Rainer, Kolbe, Karin, Mayer, Jiri, Maertens, Johan A., Linkesch, Werner, Holler, Ernst, Koza, Vladimir, Bornhäuser, Martin, Einsele, Hermann, Kolb, Hans-Jochem, Bertz, Hartmut, Egger, Matthias , Grishina, Olga and Finke, Jürgen
(2011)
Chronic graft-versus-host disease: long-term results from a randomized trial on graft-versus-host disease prophylaxis with or without anti–T-cell globulin ATG-Fresenius.
Blood 117 (23), pp. 6375-6382.
Fulltext not available.
2009
Finke, Jürgen, Bethge, Wolfgang A, Schmoor, Claudia, Ottinger, Hellmut D, Stelljes, Matthias, Zander, Axel R, Volin, Liisa , Ruutu, Tapani, Heim, Dominik A, Schwerdtfeger, Rainer, Kolbe, Karin, Mayer, Jiri, Maertens, Johan A, Linkesch, Werner, Holler, Ernst, Koza, Vladimir, Bornhäuser, Martin, Einsele, Hermann, Kolb, Hans-Jochem, Bertz, Hartmut, Egger, Matthias , Grishina, Olga and Socié, Gérard
(2009)
Standard graft-versus-host disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated donors: a randomised, open-label, multicentre phase 3 trial.
The Lancet Oncology 10 (9), pp. 855-864.
Fulltext not available.
, Ruutu, Tapani, Heim, Dominik A, Schwerdtfeger, Rainer, Kolbe, Karin, Mayer, Jiri, Maertens, Johan A, Linkesch, Werner, Holler, Ernst, Koza, Vladimir, Bornhäuser, Martin, Einsele, Hermann, Kolb, Hans-Jochem, Bertz, Hartmut, Egger, Matthias , Grishina, Olga and Socié, Gérard
(2009)
Standard graft-versus-host disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated donors: a randomised, open-label, multicentre phase 3 trial.
The Lancet Oncology 10 (9), pp. 855-864.
Fulltext not available.